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Selective serotonin reuptake inhibitors are themostwidelyprescribeddrugs targeting theCNSwith acute and chronic effects in cognitive,
emotional and behavioral processes. This suggests thatmicrocircuits of the human cerebral cortex are powerfullymodulated by selective
serotonin reuptake inhibitors, however, direct measurements of serotonergic regulation on human synaptic interactions are missing.
Usingmultiple whole-cell patch-clamp recordings fromneurons in acute cortical slices derived fromnonpathological human samples of
the prefrontal cortex, we show that neuronal assemblies triggered by single action potentials of individual neurons in the human cortex
are suppressedby therapeutic doses of fluoxetine (Prozac). This effect is boosted and canbemimickedbyphysiological concentrations of
serotonin through 5HT-2A and 5HT-1A receptors. Monosynaptic excitatory connections from pyramidal cells to interneurons were
suppressed by application of serotonin leaving the monosynaptic output of GABAergic cells unaffected. Changes in failure rate, in
paired-pulse ratio, and in the coefficient of variation of the amplitude of EPSPs suggest a presynaptic action of serotonin. In conclusion,
activation of neuronal assemblies, which were suggested as building blocks of high order cognitive processes, are effectively downregu-
lated by the acute action of selective serotonin reuptake inhibitors or serotonin at the site of pyramidal output in humanmicrocircuits.
Introduction
The introduction of fluoxetine (Prozac) and other selective sero-
tonin reuptake inhibitors (SSRIs) has changed the treatment of
depressive disorders (Wong et al., 1974; Wong et al., 1995)
through acute and chronic effects (Lucki, 1998;Hoyer et al., 2002;
Schmitt et al., 2006; Cools et al., 2008; Arnsten, 2009). The chem-
ical hypothesis of depression emphasizes that the imbalance in
the function of the serotonergic system is reinstated by SSRIs by
elevating serotonin (5-HT) levels (Maes andMeltzer, 1995;Manji
et al., 2001; Castre´n, 2005), but alternative hypotheses have also
been proposed (Lacasse and Leo, 2005; Krishnan and Nestler,
2008, 2010; Luscher et al., 2011). Nevertheless, it is generally
recognized that early changes in emotional processing can be
achieved by acute SSRI treatment while other symptoms of de-
pression only respond to chronic medication (Lucki, 1998;
Harmer et al., 2003; Cools et al., 2008; Harmer, 2008).
The prefrontal cortex, having prominent serotonergic inner-
vation in humans (Raghanti et al., 2008), contributes predomi-
nantly to functions affected by SSRIs and was shown to be crucial
in stress, depression and anxiety (Lucki, 1998; Celada et al., 2004;
Cools et al., 2008; Arnsten, 2009). Humans (Harmer et al., 2003;
Schmitt et al., 2006) and animals (Clarke et al., 2004; Brigman et
al., 2010) display altered cognitive performance after having their
central 5-HT level experimentally manipulated. With limited
studies performed on human pyramidal cells (McCormick and
Williamson, 1989; Newberry et al., 1999), our current knowledge
about synaptic mechanisms of 5-HT in the cortex is based on
non-human in vitro experiments in which micromolar concen-
trations of 5-HT were applied (Andrade and Nicoll, 1987;
Aghajanian and Marek, 1997; Schmitz et al., 1998b; Ciranna,
2006; Zhong et al., 2008). However, single spikes in serotonergic
axons produce extrasynaptic concentrations of 50–100 nM and
the maximal concentration achieved by electrical stimulation is
500–800 nM (Bunin andWightman, 1998) and few studies tested
the effect of nanomolar serotonin concentrations (Boeijinga and
Boddeke, 1993; Winterer et al., 2011).
An emerging feature of the human microcircuit is that single
action potentials in pyramidal cells frequently elicit polysynaptic
PSPs in neighboring neurons due to selective spike-to-spike cou-
pling to GABAergic basket and axoaxonic cells (AACs) which
mediate concomitant feedforward inhibition and excitation of
pyramidal cells, respectively (Szabadics et al., 2006; Molna´r et al.,
2008) leading to network activation lasting approximately an or-
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der ofmagnitude longer than detected previously in other species
(Miles, 1990; Molna´r et al., 2008; Silberberg, 2008; Woodruff et
al., 2009). Thus, the activity of a single humanneuron is sufficient
for driving a relatively widespread functional assembly of neu-
rons which were suggested to participate in higher order brain
functions (Hebb, 1949; Abeles, 1991; Brecht et al., 2004; Ikegaya
et al., 2004; Gelbard-Sagiv et al., 2008; Pastalkova et al., 2008).
Here we investigate whether therapeutic concentrations of
fluoxetine and physiological concentrations of 5-HT influence
single cell-initiated polysynaptic postsynaptic potentials in
slices of the human prefrontal cortex. Our results indicate that
recruitment of neuronal assemblies could be suppressed by
fluoxetine and 5-HT due to the modulation of local glutama-
tergic transmission.
Materials andMethods
All procedures were performed according to the Declaration of Helsinki
with the approval of theUniversity of Szeged Ethical Committee.Human
slices were derived frommaterial which had to be removed to gain access
for the surgical treatment of deep brain tumors from prefrontal regions
(gyrus frontalis superior and medialis of either hemispheres and right
gyrus frontalis inferior, the left gyrus frontalis inferior was avoided to
keep Broca’s area intact) with written informed consent of 26 male and
24 female patients (48 16 and 53 17 years of age, respectively) before
surgery over the last 6 years. Patients with premedication with SSRIs or
other drugs related to the monoamine system were excluded from the
study. Anesthesia was inducedwith intravenousmidazolam and fentanyl
(0.03 mg/kg, 1–2 g/kg, respectively). A bolus dose of propofol (1–2
mg/kg) was administered intravenously. To facilitate endotracheal intu-
bation, the patient received 0.5 mg/kg rocuronium. After 120 s the tra-
chea was intubated and the patient was ventilated with a mixture of
O2/N2O at a ratio of 1:2. Anesthesia was maintained with sevoflurane at
MAC volume of 1.2–1.5. Blocks of tissue were immersed into ice-cold
solution containing (in mM) 130 NaCl, 3.5 KCl, 1 NaH2PO4, 24
NaHCO3, 1 CaCl2, 3 MgSO4, 10 D-()-glucose, saturated with 95% O2
and 5%CO2 in the operating theater, sliced at a thickness of 350mwith
a vibrating blademicrotome (MicromHM650 V) and were incubated at
room temperature for 1 h in the same solution. The solution used during
recordings differed only in that it contained 2 mM CaCl2 and 1.5 mM
MgSO4. Recordings were obtained at36°C from up to four concomi-
tantly recorded cells visualized in layer 2/3 by infrared differential inter-
ference contrast videomicroscopy at depths 60–130m from the surface
of the slice. Access resistance was monitored with10 mV voltage steps
in between experimental epochs and data collection was terminated if
access resistance exceeded 30M. Signalswere filtered at 8 kHz, digitized
at 16 kHz and analyzed with PULSE software. Micropipettes (5–7 M)
were filled with a low [Cl]i solution for discriminating GABAergic and
glutamatergic events containing (inmM) 126 K-gluconate, 4 KCl, 4 ATP-
Mg, 0.3 GTP-NA2, 10 HEPES, 10 phosphocreatine, and 8 biocytin (pH
7.20; 300mOsm). Presynaptic cells were stimulated with brief (2–10ms)
suprathreshold pulses delivered at7 s intervals, to minimize intertrial
variability. Membrane properties of human neurons or polysynaptic
events did not show significant changes for up to 20 h after slicing, but
recordings included in the analysis were arbitrarily terminated 15 h after
slice preparation. Traces shown are single sweeps or averages or of 20–
100 consecutive episodes. The time window in which effects were quan-
tified was 60 ms. Time points of polysynaptic events used for raster plots
were determined as the onset of PSPswith automatizedmacroswritten in
Origin software (Microcal). The effects during drug application were
tested following a 5 min wash-in and 25 min wash-out periods. Data
are given as mean SD,Wilcoxon signed-rank test andMann–Whitney
U test was used to compare datasets using Statistica software (StatSoft
Inc.), differences were accepted as significant if p 0.05. Visualization of
biocytin and microscopy was performed as described earlier (Szabadics
et al., 2006; Molna´r et al., 2008).
Results
Human pyramidal cell-evoked polysynaptic events are
modulated by fluoxetine and serotonin
We performed simultaneous dual, triple, and quadruple whole-
cell patch-clamp recordings from neurons in layer 2/3 of acute
human brain slices cut fromnonpathological samples of prefron-
tal cortex of 26male and 24 female patients (48 16 and 53 17
years of age, respectively). The study is based on 200 cells re-
corded from 84 slices. We found no correlation with age or gen-
der in any of the datasets presented below.
Single spikes were elicited in pyramidal cells while looking for
polysynaptic excitatory and/or IPSPs in simultaneously recorded
neurons. We examined the frequency of single-spike-triggered
polysynaptic events within a 60 ms time window following the
trigger spike before and during application of 5-HT. To deter-
mine the sensitivity of polysynaptic events to 5-HT, we applied
5-HT in a wide range of concentrations (10 nM–40 M) with
values chosen to correspond to physiologically relevant concen-
trations (10 nM, 100 nM, 500 nM) (Malagie´ et al., 1995) and—to
compare our data to earlier results—to micromolar concentra-
tion values applied in previous studies (40 M) (Schmitz et al.,
1998a,b).
We did not detect a significant decrease in the frequency of
polysynaptic events relative to control when 10 nM 5-HT was
applied (n 6; 22.4 7.6 Hz vs 20.2 6.1 Hz; p 0.13), but a
robust suppression of polysynaptic events occurred when 100 nM
5-HT was applied decreasing the frequency of polysynaptic
events from 33.5 16.6 Hz to 7.4 6.9 Hz (n 7, p 0.01; Fig.
1A,B). Application of 500 nM and 40M concentrations of 5-HT
completely abolished single action potential-triggered polysyn-
aptic events decreasing their frequency from 31.5  21.9 Hz to
1.1 1.22 Hz; (n 5, p 0.03) and from 27.5 18 Hz to 2.6
2.8 Hz; (n 3, p 0.05), respectively (Fig. 1B). We then asked
whether therapeutically relevant concentrations of fluoxetine (10
M) (Bolo et al., 2000) had a modulatory effect on feedforward
assemblies (Fig. 1C). Action potential elicited in single pyramidal
cells activated downstream networks with an average frequency
of polysynaptic events of 21.6  3.4 Hz measured in simultane-
ously recorded neurons (n 9). Fluoxetine (10 M) suppressed
the frequency of single-spike-triggered polysynaptic events to
19.0 2.6 Hz (p 0.03; Fig. 1C,D). The slicing procedure cuts
subcortical serotonergic afferents arriving to the prefrontal cor-
tex sampled, thus we supplemented 5-HT in close to physiologi-
cal baseline concentration (10 nM) (Malagie´ et al., 1995) which
had no effect on polysynaptic events alone to the extracellular
solution after measuring the effect of fluoxetine alone. 5-HT (10
nM) combined with fluoxetine (10 M) resulted in further sup-
pression of the frequency of single action potential-triggered
polysynaptic potentials (10.4  3.3 Hz; p  0.01; Fig. 1C,D)
relative to fluoxetine alone.
Networkmechanisms underlying serotonergic suppression of
single cell-initiated network events
Pyramidal cell-triggered polysynaptic activity requires both glu-
tamatergic and GABAergic synaptic transmission and synapti-
cally activated GABAergic cells could mediate inhibitory as well
as excitatory effects of pyramidal cells (Miles, 1990; Szabadics et
al., 2006; Molna´r et al., 2008; Glickfeld et al., 2009; Woodruff et
al., 2009). Thus, 5-HT could suppress pyramidal cell-triggered
network activity through several mechanisms (Fig. 2A). A plau-
sible explanation for the suppression of feedforward excitation by
fluoxetine and 5-HT is the serotonergic hyperpolarization of
GABAergic neurons. The firing of fast spiking GABAergic in-
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terneurons in the rat can be increased in response to 5-HT and
fluoxetine via 5-HT 2 receptors (Zhong and Yan, 2011) making
this scenario unlikely, but fast spiking cells containing 5HT-1A
receptors could also be downregulated as demonstrated in vivo
(Puig et al., 2010). In our sample, GABAergic neurons showed
various electrophysiological and morphological properties. De-
tailed electrophysiological characterization of themain interneu-
ron subtypes in the human is lacking, thus we discriminated
Figure 1. Pyramidal cell-triggered polysynaptic events and their modulation by 5-HT and fluoxetine. A, Top, Action potentials elicited in a single pyramidal cell (pyramid pre) initiated
sequences of events composed of monosynaptic EPSPs followed by polysynaptic EPSPs after the first action potential and monosynaptic EPSPs followed by polysynaptic IPSPs after the
second presynaptic spike detected in the a postsynaptic pyramidal cell (pyramid post). Bottom, Scattergram of the onset of EPSPs (gray dots) and IPSPs (black dots) arriving to the
postsynaptic pyramidal cell during 35 consecutive sweeps in control conditions and when applying 100 nM 5-HT. Polysynaptic EPSPs as well as IPSPs are abolished by 5-HT. B, Average
changes across trials in the frequency of polysynaptic events (pPSPs) triggered by single spikes of individual pyramidal cells in response to various 5-HT concentrations. C, Top, Action
potentials in a pyramidal cell (pyramid pre) elicited polysynaptic IPSPs in a postsynaptic pyramidal cell (pyramid post). Fluoxetine (10M) decreased the frequency of polysynaptic IPSPs
(middle) and this effect was further enhanced by 10 nM 5-HT (bottom). D, Average changes across trials in the frequency of polysynaptic events triggered by single spikes of individual
pyramidal cells in response to fluoxetine alone (10M, flx) and coapplied with 10 nM 5-HT. *p 0.05.
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Figure 2. Sensitivity of humanmonosynaptic connections to serotonin and fluoxetine.A, Schematic drawings of a polysynaptic circuit suggested to be responsible for the polysynaptic responses
triggered by presynaptic pyramidal cell (pre, continuous triangle) and detected in postsynaptic pyramidal cells (post, continuous triangle), based on the work of Molna´r et al. (2008) Polysynaptic
inhibition (pIPSP) and excitation (pEPSP) could be mediated by various GABAergic interneurons (int) and by axoaxonic cells (aac), respectively. 5-HT and fluoxetine could suppress polysynaptic
events through various networkmechanisms highlighted by shaded areas.B, Changes in the restingmembrane potential of interneurons (int) and pyramidal cells (pyr) in response to 100 nM 5-HT.
Ca, Firing patterns of a reciprocally coupled pyramidal cell (pyr, gray) and basket cell (basket, black). Cb, Unitary IPSPs from the basket cell to the pyramidal cell were unaffected by 100 nM 5-HT. Cc,
Monosynaptic EPSPs from the pyramidal cell to the basket cell were reversibly reduced by 100 nM 5-HT. Cd, Left, Axon terminals of the basket cells in close appositions with unstained somata were
observed with differential interference contrast microscopy. Right, Bright-field photomicrograph of a suspected perisomatic autapse of the basket cell. (Figure legend continues.)
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basket cells and axoaxonic cells fromother interneurons based on
light microscopically identified axonal branches forming periso-
matic baskets or characteristic axonal cartridges or candles, re-
spectively (Somogyi et al., 1998; Szabadics et al., 2006).We found
no differences between GABAergic cells in any of the properties
investigated belowandwepooled the data and indicate the fraction
of axoaxonic and basket cells in each paradigm. We found resting
membrane potential of human GABAergic neurons to be depolar-
ized by 3.24 2.1 mV (n 15, p 0.001; 8 basket cells, 7 uniden-
tified; Fig. 2B) during application of 100 nM 5-HT, but rheobasic
currents and action potential threshold potentials remained un-
changed relative to control. Accordingly, the decreased frequency of
polysynaptic IPSPs in humannetworks is not basedon the hyperpo-
larization of GABAergic cells.
Alternatively, to test whether serotonergic suppression of
IPSPs occur at GABAergic release sites, we recorded unitary
IPSPs from interneuron to pyramidal cell pairs before and
during application of 100 nM 5-HT (Fig. 2C). We recorded
from 6 interneuron to pyramidal cell connections identifying
5 presynaptic interneurons as basket cells. The amplitude of
unitary IPSPs was similar regardless the presence of 100 nM
5-HT (2.23 1.0 mV and2.42 0.9 mV, respectively; n
6; p 0.13; Fig. 2C,G) showing that GABAergic axon terminals
were not modulated by 5-HT. Apart from GABAergic compo-
nents of the microcircuit, serotonergic effects might target the
function of pyramidal cells (Boeijinga and Boddeke, 1993, 1996;
Schmitz et al., 1998a,b; Newberry et al., 1999). First we investi-
gated the effects of 100 nM 5-HT on the restingmembrane poten-
tial of pyramidal cells. No significant change was observed in the
membrane potential of pyramidal cells in the presence of 5-HT
relative to control (1.13 2.12mV; p 0.17; Fig. 2B). However,
serotonergic suppression of polysynaptic event recruitment de-
tailed above could result from the modulation of the output of
pyramidal cells rather than from changes in their intrinsic mem-
brane properties. We tested the effects of 5-HT on pyramidal
cell-triggered monosynaptic EPSPs in 50 and 100 nM concentra-
tions corresponding to local extrasynaptic 5-HT concentrations
reported after one or two action potentials were fired by seroto-
nergic fibers, respectively (Bunin andWightman, 1998). The two
concentrations gave similar results, thus data were pooled. Ap-
plication of nanomolar 5-HT (50 or 100 nM) decreased the am-
plitude of unitary pyramidal cell to pyramidal cell (n  6; from
1.56 1.09 to 1.27 1.09 mV; p 0.03; Fig. 1A) and pyramidal
cell to interneuron connections (n 12, 1 pyramidal to AAC and
9 pyramidal to basket cell connections; from 4.34  2.52 to
3.15 2.53 mV; p 0.01; Fig. 2C,G). Moreover, the presence of
nanomolar 5-HT effectively eliminated spike-to-spike coupling
in pyramidal cell to interneuron connections showing suprath-
reshold postsynaptic responses with a probability of 13.6% and
83.6% in control conditions (n 2, Fig. 2D). Furthermore, flu-
oxetine (10 M) reduced unitary EPSP amplitudes in pyramidal
cell to interneuron connections (postsynaptic interneurons: 1
aac, 2 basket and 12 unidentified) from5.49 4.55 to 4.45 3.22
mV (n 15; p 0.02; Fig. 2F). Combination of 5-HT (50 or 100
nM) with fluoxetine (10 M) caused a significantly enhanced de-
crease in the amplitude of unitary pyramidal cell to interneuron
EPSPs relative to the effect of 5-HT (p 0.01) or fluoxetine (p
0.01) alone (n 7; from 5.46 3.91 to 3.50 3.48mV; p 0.01;
Fig. 2H).
To localize the site of serotonergic action to the presynaptic or
postsynaptic side of pyramidal output, we analyzed several pa-
rameters of unitary EPSPs arriving to pyramidal cells and in-
terneurons and pooled the data due to similar results. The
probability of failures for single presynaptic action potentials to
evoke an EPSP increased from 3.68  8.07% in control to
11.38 17.03% in 5-HT (50 or 100 nM;n 19; p 0.02; Fig. 2E),
indicating that the probability of glutamate release from pyrami-
dal cell terminals was decreased by 5-HT. Relative to control,
serotonin increased the paired-pulse ratio of EPSP amplitudes
(EPSP2/EPSP1) evoked by presynaptic spikes separated by a 60
ms interval from 0.94 0.18 to 1.04 0.19, respectively (n 14,
p  0.04; Fig. 2C,E). Moreover, the coefficient of variation of
EPSP amplitudes increased from 0.20 0.11 to 0.38 0.38 (n
16, p 0.02). In addition, 5-HT did not change the input resis-
tance of postsynaptic neurons at the resting membrane potential
(189.4 170.37 in control and 188.7 171.15 in 5-HT, n 10,
p 0.96).
Apart from the selectively strong coupling between human
pyramidal cells and GABAergic interneurons leading to feed-
forward spike-to-spike coupling, human AACs are also
capable of triggering neuronal assemblies composed of mono-
synaptic IPSPs, disynaptic EPSPs and polysynaptic IPSPs and
EPSPs (Szabadics et al., 2006; Molna´r et al., 2008). While py-
ramidal cell-triggered polysynaptic IPSPs and EPSPs were
uniformly sensitive to 5-HT, axoaxonic cell-triggered poly-
synaptic events showed distinct serotonin sensitivity. The fre-
quency of disynaptic EPSPs—corresponding to selective
GABAergic recruitment of pyramidal cells (Szabadics et al., 2006;
Molna´r et al., 2008)—was not affected even by high concentra-
tions of 5-HT (40M)which completely and reversibly abolished
polysynaptic IPSPs andEPSPs (n 1, data not shown; for control
conditions, see Molna´r et al., 2008, their Fig. 6C).
The results above suggest that glutamatergic synapses estab-
lished by local pyramidal cells could be the predominant targets
through which 5-HT and fluoxetine exert their modulation of
human feedforward microcircuits and that inhibitory and excit-
atory output of basket and axoaxonic cells, respectively, seemed
to not be affected by physiological concentrations of 5-HT. Ac-
cording to these results and similar to unidentified glutamatergic
synapses in the rat entorhinal cortex (Schmitz et al., 1998a,b), it is
very likely that 5-HT act on the presynaptic site of glutamatergic
synapses established by layer 2/3 pyramidal cells in human.
Pharmacology of 5-HT-induced suppression of mono- and
polysynaptic events
The prefrontal cortex is enriched in 5HT-1A, 5HT-2A and 5-HT
3 receptors in rodents, primates and humans (Jakab and
Goldman-Rakic, 2000; DeFelipe et al., 2001; Celada et al., 2004;
Santana et al., 2004; de Almeida and Mengod, 2007; Puig et al.,
2010). We examined how selective activation of 5-HT receptors
influences poly- and monosynaptic events triggered by pyrami-
dal or AACs. The 5-HT2 receptor agonist -methylserotonin (40
4
(Figure legend continued.) D, Spike to spike coupling between a pyramidal cell and its postsyn-
aptic interneuron with a probability of 13.6%were silenced by 100 nM 5-HT accompanied by a
decrease in the amplitude of subthreshold EPSPs. Ea, The reliability and amplitude of unitary
EPSPs from a pyramidal cell to an axoaxonic cell (aac) is reversibly decreased in the presence of
50 nM 5-HT suggesting a presynaptic effect. Eb, Lightmicrographs of characteristic cartridges of
vertically arranged axon terminals of the axoaxonic cell. F, Action potentials elicited in the
pyramidal cell-evoked monosynaptic EPSPs on a postsynaptic interneurons, which were re-
ducedby10M fluoxetine.G, Average changes across trials in the amplitudeof IPSPs andEPSPs
in pyramidal to pyramidal (p-p), and in pyramidal to interneuron connections (p-int), normal-
ized to control, in response to 50–100 nM 5-HT. *p 0.05.H, Average changes across trials in
the amplitude of EPSPs, normalized to control, in response to fluoxetine (flx, 10 M), 5-HT
(50–100 nM), and their coapplication. *p 0.05.
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M), mimicked the effect of 5-HT and
eliminated polysynaptic events evoked by
pyramidal cells (n  10, Fig. 3A). AAC-
triggered polysynaptic events were also
eliminated by -methylserotonin (40
M), but the frequency of AAC-evoked
monosynaptic IPSPs and disynaptic EP-
SPs were not affected (Fig. 4). Moreover,
-methylserotonin (40M) decreased the
average amplitude of pyramidal cell-
triggered unitary EPSPs from 3.15 2.53
mV to 1.49 1.29 mV (n 10, p 0.01;
postsynaptic cells were 4 pyramidal cells, 1
axoaxonic cell, 1 basket cell, 4 unidenti-
fied interneurons), and similarly to 5-HT,
increased the failure rate from 4.8 
10.8% to 20.4 19.8% (n 10, p 0.01),
paired-pulse ratio from 0.94  0.33 to
1.17 0.38 (n 6, p 0.04) and coeffi-
cient of variation from 0.28  0.21 to
0.59  0.26 (n  7, p  0.01) of unitary
EPSPs indicating a presynaptic effect
(Fig. 3B). Alpha-methylserotonin also
reduced spike-to-spike coupling in py-
ramidal cell to interneuron pairs from
42.6  28.8% to 3.6  3.4% together
with a decrease in the amplitude of un-
derlying subthreshold EPSPs (from
12.3  6.7 mV to 5.6  5.4 mV, n  6,
p  0.03, Fig. 3B). Although previous
experiments in the rat inferior olive
showed that 5HT-2A receptors contribute
to 5-HT-mediated endocannabinoid re-
lease which retrogradely suppresses excit-
atory synapses by activating presynaptic
CB1 receptors (Best and Regehr, 2008),
we found no effect of the CB1 antagonist
AM251 (5 M) in blocking the effects of
-methylserotonin (n 3) on pyramidal
cell-initiated polysynaptic events. In line
with earlier results showing the involve-
ment of 5HT-1A receptors in presynaptic
regulation of glutamatergic inputs
(Schmitz et al., 1998a,b), the 5HT-1A ag-
onist 8-OH-DPAT (10 M) decreased the
amplitude of unitary pyramidal cell-
evoked EPSPs from 1.3 1.2mV to 0.9
1.2mV (n 4, p 0.01, postsynaptic cells
were 3 pyramidal and 1 basket cell), in-
creased the failure rate from5.2 6.6% to
26.2  32.6 (n  4, p  0.03), paired-
pulse ratio from 1.11  0.20 to 1.48 
0.24 (n  4, p  0.05) and coefficient of
variation from 0.24 0.12 to 0.43 0.19
(n  4, p  0.05) and eliminated single
pyramidal cell-triggered polysynaptic
events (n  3, Fig. 3C–E). Other 5-HT
receptor agonists such as the 5-HT 3 re-
ceptor agonist 2-methyl-5-HT (80 M,
n  3) or the 5-HT 1B receptor agonist
CP94253 (40 M, n  2) did not influ-
ence pyramidal cell-evoked polysynaptic
events. These results suggest that the effect
Figure 3. 5-HT2A and 5-HT1A receptors contribute to suppression of human Hebbian networks. A, The 5-HT2 receptor agonist
-methylserotonin (-m-5-HT) eliminated polysynaptic IPSPs in a postsynaptic pyramidal cell (pyr post) initiated by action
potentials in the presynaptic pyramidal cell (pyr pre). B, Spike-to-spike coupling in a pyramidal cell (pyr pre) to interneuron (int
post) connection was reversibly (washout) suppressed by-methylserotonin together with a the amplitude and release proba-
bility of underlying subthreshold EPSPs. C–E, The 5-HT1A agonist 8-OH-DPAT eliminated single pyramidal cell (pyr pre)-triggered
polysynaptic events in a target pyramidal cell (pyr post, C), suppressed the amplitude and increased the failure rate and paired-
pulse ratio of presynaptic pyramidal cell (pyr pre)-evoked EPSPs on a postsynaptic pyramidal cell (pyr post,D) and an interneuron
(int post, E).
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of fluoxetine and serotonin ismediated by
5HT-2A and 5HT-1A receptors acting
presumably on axons of human pyrami-
dal cells.
Discussion
The serotonergic system is under intensive
focus of research as it is implicated in co-
gnitive impairments in several psychiatric
disorders such as depression, anxiety,
schizophrenia or Alzheimer disease (Lucki,
1998; Meltzer et al., 1998; Jones and Black-
burn, 2002; Castaneda et al., 2008) and thus
a favorable target for cognitive improve-
ment in psychiatric disorders (Roth et al.,
2004). The antidepressant SSRIs elevate ex-
tracellular 5-HT concentrations (Malagie´ et
al., 1995) by blocking 5-HT reuptake and
exert beneficial effects on cognitive func-
tions. Human cortical networks are salient
in a sense that sparse activity of single pyra-
midal cells could recruit relatively wide-
spread cell assemblies (Molna´r et al., 2008)
proposed to play role in higher order corti-
cal functions (Hebb, 1949), however how
SSRIsor5-HT influence assemblyorganiza-
tion has not been investigated.
Applying multiple whole-cell patch-
clamp recordings in nonepileptic human
prefrontal cortical slices, we investigated
the effect of the widely prescribed antide-
pressant fluoxetine and the endogenous
neuromodulator 5-HT on single cell-
initiated network events.Our results show
that series of microcircuit events impli-
cated in the operation of cognitive pro-
cesses are effectively modulated by 5-HT
and by pharmacological blockade of the
5-HT reuptake system. Using physiologi-
cal and therapeutic concentrations of
5-HT and fluoxetine, respectively, we
identified the synapses from pyramidal
cells to GABAergic interneurons as the
site of action in human feedforward cir-
cuits and suggest that the modulation tar-
gets the presynaptic side of these synapses.
Among postsynaptic GABAergic cells we
identified two cell populations namely the
AAC and basket cells EPSPs arriving onto
which were sensitive to 5-HT. EPSPs ar-
riving to other interneuron populations
might also be sensitive to 5-HT since our
sample contained other interneurons
which did not belong to these two classes.
We activated single neurons (pyramidal
Figure4. Axoaxonic cell-triggeredpolysynaptic events showingdifferent sensitivity to5-HT2A receptor agonist.A, Single action
potentials in four axoaxonic cells (aac) triggered mono- and polysynaptic events detected in the aac itself (top) and in its down-
stream pyramidal cells (bottom) innervated mono- as well as polysynaptically in control (left) and in 40 M -methyl-5-HT
(a-m-5-HT, right).B, Scattergramof the onset of EPSPs (red dots) and IPSPs (blue dots) from20 consecutive sweeps superimposed
from the same experiments as inA in control (left) and in 40M-methyl-5-HT (a-m-5-HT, right). C, Probability histograms from
4
the onset time of EPSPs (gray) and IPSPs (black) constructed
from A and B showing the alternating sequences of IPSPs and
EPSPs triggered by the axoaxonic cells. The probability of
monosynaptic IPSPs and disynaptic EPSPs was unchanged in
-methyl-5-HT, but other polysynaptic events were abol-
ished. A–C show the same time window.
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cells or interneurons) to study the SSRI’s consequence on recruit-
ment of polysynaptic ensembles and release of 5-HTby activation
of serotonergic fibers can be excluded given that corelease of
5-HT from glutamatergic or GABAergic terminals has not been
described. The effect of fluoxetine on polysynaptic events
(10%) appears relative small compared with the effect of sero-
tonin (70%). A possible explanation for this could be the as-
sumption that the slice preparation contains either ambient
serotonin or spontaneously active serotonergic fibers leading to
the observed fluoxetine-dependent reduction in polysynaptic
activity.
Our analysis of multiple parameters of monosynaptic excit-
atory connections indicate a presynaptic mechanism of action of
5-HT at glutamatergic synapses possibly mediated by 5HT-1A
and 2A receptors. 5HT-1A and 2A receptors are considered to
have opposite effects on the excitability of postsynaptic neurons
(Newberry et al., 1999; Andrade, 2011). Although 5HT-2A recep-
tors have a relatively low affinity for serotonin (Barnes and Sharp,
1999), suppression of glutamate release with 5-HT mediated by
both of these two receptor types was shown in the cerebellum
(Maura et al., 1988) and 5-HT 1-A-mediated presynaptic de-
crease of glutamatergic transmission was reported in the entorhi-
nal cortex of rat (Schmitz et al., 1998a,b) in addition to our
experiments.
Apart from axon terminals, the proximal part of the axon
initial segment of pyramidal cells reportedly expressing 5HT-1A
receptors (DeFelipe et al., 2001) could also contribute to seroto-
nergic effects, possibly by gating the propagation of action poten-
tials between the somatodendritic and axonal compartment
through local hyperpolarization (Newberry et al., 1999). In line
with a previous study (Newberry et al., 1999) a minor fraction of
pyramidal cells were hyperpolarized by 5-HT. Serotonergic hy-
perpolarization at the axon initial segment via 5HT-1A receptors
should increase the driving force for the depolarizing GABAergic
input arriving from AACs (Khirug et al., 2008; Woodruff et al.,
2009) supporting our results showing reliable disynaptic EPSPs
due to spike triggering in pyramidal neurons by AACs in the
presence of 5-HT. However, 5HT-2A receptor activation usually
regarded as excitatory (Aghajanian and Marek, 1997) and impli-
cated in a wide range of functions ranging from dendritic excita-
tion in the neocortex (Aghajanian and Marek, 1997) to
presynaptic facilitation (Hasuo et al., 2002) or depression (Best
and Regehr, 2008) of glutamatergic transmission in subcortical
areas also led to the suppression of glutamate-dependent feedfor-
ward network events. Moreover, activation of 5HT-2A receptors
were found to suppress neuronal firing in the prefrontal cortex of
monkeys while performing a working memory task (Williams et
al., 2002).
We also investigated the output of two types of GABAergic
neuron, AACs and basket cells which could mediate feedforward
excitation/inhibition and feedforward inhibition, respectively,
onto pyramidal cells. We found no evidence for 5-HT sensitivity
of synapses established by these two GABAergic cell types on
pyramidal neurons. Primates and rodent interneurons are di-
verse and heterogeneous regarding the expression of 5-HT recep-
tors as well as in their intrinsic responses to 5-HT (Jakab and
Goldman-Rakic, 2000; Foehring et al., 2002; Xiang and Prince,
2003), thus our results do not rule out the possibility of selective
strengthening or weakening of inhibitory pathways in the neo-
cortex by 5-HT. However, in contrast to what was found in ro-
dents (Foehring et al., 2002; Xiang and Prince, 2003), membrane
potentials of various interneuron types were uniformly depolar-
ized in response to 5-HT which could be attributed to restricted
sampling or to interspecies differences. Indeed, interspecies dif-
ferencesmight exist, since 5HT-1A receptormRNAwas shown to
be expressed in amuch larger fraction of parvalbumin-expressing
neurons, mainly corresponding to basket and axoaxonic cells, in
the rat compared with the primate prefrontal cortex (de Almeida
and Mengod, 2008; Puig et al., 2010). Our results are in agree-
ment with previous studies achieved by extracellular stimulation
in the rat entorhinal cortex (Schmitz et al., 1998a) showing that
the 5-HT sensitivity of polysynaptic events was due to the sup-
pression of glutamatergic inputs arriving to interneurons, while
GABAergic outputs were not modulated. However, our results
are in contrast with other studies which found that the strength of
basket cell to pyramidal cell connections was decreased by 5-HT
in mouse somatosensory cortex further suggesting brain region-
or species-related differences (Kruglikov and Rudy, 2008). To-
gether, the results show that the serotonergic switch works on
glutamatergic synapses and leaves the GABAergic component of
human feedforward assemblies intrinsically intact but deacti-
vated in the presence of 5-HT allowing rapid reorganization and
reactivation during cognitive tasks as suggested by the alterations
in cognitive performance during acute effects of SSRIs (Harmer
et al., 2003; Harmer, 2008). However, one should be cautious in
interpreting the fluoxetine results as only mediated by increases
of ambient 5-HT, because fluoxetine is known to raise extracel-
lular concentrations of norepinephrine and dopamine (Maes and
Meltzer, 1995; Manji et al., 2001; Krishnan and Nestler, 2008).
Importantly, fluoxetine exerts its antidepressant action only after
several weeks of treatment, thus, while our experiments have a
clear relevance to the acute effects of SSRIs, slow therapeutic
effects of fluoxetine remain unclear.
The prefrontal cortex is crucial in stressor controllability by
inhibiting the activity of the serotonergic dorsal raphe nucleus
(Amat et al., 2005). However, in severe or chronic stress, prefron-
tal control over the dorsal raphe is overcome by increased extra-
cellular level of prefrontal 5-HT (Bland et al., 2003), resulting in
disruption of cognitive processes (Cerqueira et al., 2007). Tem-
porary increase in anxiety and threat processing was observed in
some patients early in acute SSRI treatment before anxiolytic
actions were seen (Kent et al., 1998; Burghardt et al., 2004;
Harmer, 2008). It may be possible, therefore, that the early effect
of fluoxetine disrupting local neuronal assembly organization in
prefrontal cortex by suppressing local glutamatergic and feedfor-
ward GABAergic connections may contribute to these symp-
toms. Acute effects of antidepressants could also be important in
the development of their subsequent chronic effects (Castre´n,
2005; Harmer, 2008). According to the relatively recent network
hypothesis, problems in neuronal communication could bemore
important in depression compared with chemical imbalance and
antidepressants might improve information processing in im-
paired neuronal networks by causing functional and structural
changes (Manji et al., 2001; Nestler et al., 2002; Castre´n, 2005).
Impaired plasticity might underlie the pathophysiology of de-
pression (Manji et al., 2001) and control of feedforward inhibi-
tion by serotonergic downregulation as shown here might
contribute to the effects of 5-HT on plasticity in cortical struc-
tures (Kojic et al., 2000; Bissie`re et al., 2003; Zhong et al., 2008).
Indeed, by reducing intracortical inhibition, fluoxetine restored
plasticity in adult rats and promoted recovery of visual functions
in amblyopic animals (Maya Vetencourt et al., 2008). Thus, re-
organization of feed forward connections could initiate changes
in neuronal assembly formation which might serve as a starting
point of chronic changes in the cortical network.
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